Table 1.
Long-term follow-up of 107 female AHP patients.
| AIP n = 65 |
VP n = 40 |
HCP n = 2 |
Total n = 107 |
|
|---|---|---|---|---|
| Current age (2015) | 50 (15–84) | 57 (18–85) | 52 (37–67) | 54 (15–85) |
| Age at diagnosis | 21 (0–47) | 33 (13–76) | 25 (16–33) | 24 (0–76) |
| Mode of presentation (%) | ||||
| Acute attacks (hospitalization) | 26 (40) | 15 (38) | 2 (100) | 43 (40) |
| Acute symptoms solely (no hospitalization) | 18 (28) | 9 (23) | 0 | 27 (25) |
| Cutaneous symptoms | 21 (53) | 0 | 21 (20) | |
| Asymptomatic | 21 (32) | 7 (18) | 0 | 28 (26) |
| Median age at symptom onset and end (range, years) | ||||
| Onset of acute symptoms | 23 (10–57) | 25 (11–48) | 16, 33 | 23 (10–57) |
| Onset of cutaneous symptoms | 26 (10–48) | |||
| First hospitalization | 25 (15–57) | 31 (21–44) | 16, 34 | 27 (15–57) |
| Last hospitalization | 27 (16–57) n = 23 |
37 (21–64) n = 15 |
16, 34 n = 2 |
29 (16–64) n = 40 |
| End of acute symptoms | 33 (14–57) n = 24 |
40 (15–76) n = 16 |
16 n = 1 |
37 (14–76) n = 41 |
| Time period of acute symptoms if ended (years) | 5 (<1–43) | 11 (<1–54) | <1 | 8 (<1–54) |
| Patients with acute symptoms during the past year (%) | 17/44 (39) | 7/24 (29) | 1 / 2 (50) | 25/70 (36) |